Scrip
Interview: Rexbio sets sights on novel approach to pancreatic cancer
08 February 2010
Ian Haydock
Please Login to read the full article.
08 February 2010
Ian Haydock
ian.haydock@informa.com
The South Korean bioventure Rexbio is looking to develop a novel approach to the treatment and diagnosis of one of the most deadly forms of cancer by targeting a gene found to be closely linked to the malignancy.
The small, privately held company is focusing on pancreatic adenocarcinoma up-regulated...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pfizer halts enrolment in Phase III lung cancer trial of novel anticancer
- ArQule's lead development project set for Phase III lung cancer trial
- Nexavar fails second Phase III trial in newly diagnosed advanced lung cancer
- Fuso taps Otsuka as Japanese partner for cancer vaccine
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
